OM
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Alyeska Investment Group, L.P.
· Exited
Change
−1.6M
Δ Own
−100.0%
Date
Q1 2026
|
Alyeska Investment Group, L.P. | Exited· Q1 2026 | – | −1.6M | −100.0% | Q1 2026 | |||||
|
Bml Capital Management, LLC
· Added
Change
+1.4M
Date
Q1 2026
|
Bml Capital Management, LLC | Added· Q1 2026 | – | +1.4M | – | Q1 2026 | |||||
|
Woodline Partners LP
· Reduced
Change
−1.0M
Date
Q1 2026
|
Woodline Partners LP | Reduced· Q1 2026 | – | −1.0M | – | Q1 2026 | |||||
|
AQR Capital Management LLC
· Added
Change
+628K
Date
Q1 2026
|
AQR Capital Management LLC | Added· Q1 2026 | – | +628K | – | Q1 2026 | |||||
|
Stratos Wealth Partners, Ltd.
· New
Change
+201K
Date
Q1 2026
|
Stratos Wealth Partners, Ltd. | New· Q1 2026 | – | +201K | – | Q1 2026 | |||||
|
UBS Group AG
· Added
Change
+179K
Date
Q1 2026
|
UBS Group AG | Added· Q1 2026 | – | +179K | – | Q1 2026 | |||||
|
Renaissance Technologies LLC
· Added
Change
+177K
Δ Own
+391.3%
Date
Q1 2026
|
Renaissance Technologies LLC | Added· Q1 2026 | – | +177K | +391.3% | Q1 2026 | |||||
|
Marshall Wace, LLP
· Exited
Change
−171K
Δ Own
−100.0%
Date
Q1 2026
|
Marshall Wace, LLP | Exited· Q1 2026 | – | −171K | −100.0% | Q1 2026 | |||||
|
Deutsche Bank AG
· Reduced
Change
−147K
Date
Q1 2026
|
Deutsche Bank AG | Reduced· Q1 2026 | – | −147K | – | Q1 2026 | |||||
|
Northern Trust
· Reduced
Change
−107K
Date
Q1 2026
|
Northern Trust | Reduced· Q1 2026 | – | −107K | – | Q1 2026 | |||||
|
FMR LLC
· Added
Change
+101K
Δ Own
+3.8%
Date
Q1 2026
|
FMR LLC | Added· Q1 2026 | – | +101K | +3.8% | Q1 2026 | |||||
|
Acadian Asset Management LLC
· Reduced
Change
−88K
Date
Q1 2026
|
Acadian Asset Management LLC | Reduced· Q1 2026 | – | −88K | – | Q1 2026 | |||||
|
Stifel Financial Corp
· Exited
Change
−80K
Δ Own
−100.0%
Date
Q1 2026
|
Stifel Financial Corp | Exited· Q1 2026 | – | −80K | −100.0% | Q1 2026 | |||||
|
Pura Vida Investments, LLC
· Added
Change
+78K
Date
Q1 2026
|
Pura Vida Investments, LLC | Added· Q1 2026 | – | +78K | – | Q1 2026 | |||||
|
Pfm Health Sciences, LP
· Added
Change
+64K
Date
Q1 2026
|
Pfm Health Sciences, LP | Added· Q1 2026 | – | +64K | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Brottem John L.
· Officer
Grant (A)
60K
|
Brottem John L. | Officer | Grant (A) | – | 60K | – | 90K | +197.6% | Jun 26, 2026 | Jun 29, 2026 | |||||||||
|
Gaeta Renee
· Officer
Grant (A)
72K
|
Gaeta Renee | Officer | Grant (A) | – | 72K | – | 185K | +63.0% | Jun 26, 2026 | Jun 29, 2026 | |||||||||
|
Trigg Leslie
· Director
Grant (A)
99K
|
Trigg Leslie | Director | Grant (A) | – | 99K | – | 198K | +100.3% | Jun 26, 2026 | Jun 29, 2026 | |||||||||
|
Hackett Patrick T.
· Director
Grant (A)
11K
|
Hackett Patrick T. | Director | Grant (A) | – | 11K | – | 106K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Oboyle Kevin C.
· Director
Grant (A)
11K
|
Oboyle Kevin C. | Director | Grant (A) | – | 11K | – | 35K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Prange Karen
· Director
Grant (A)
11K
|
Prange Karen | Director | Grant (A) | – | 11K | – | 29K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Lang Brent D.
· Director
Grant (A)
11K
|
Lang Brent D. | Director | Grant (A) | – | 11K | – | 29K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Grossman D. Keith
· Director
Grant (A)
11K
|
Grossman D. Keith | Director | Grant (A) | – | 11K | – | 25K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Drexler Karen
· Director
Grant (A)
11K
|
Drexler Karen | Director | Grant (A) | – | 11K | – | 21K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Gaeta Renee
· CFO
Sell
−$87K
|
Gaeta Renee | CFO | Sell | $4.94 | −18K | −$87K | 114K | – | Jun 3, 2026 | Jun 5, 2026 | |||||||||
|
Trigg Leslie
· Director
Sell
−$13K
|
Trigg Leslie | Director | Sell | $3.70 | −3K | −$13K | 99K | – | May 15, 2026 | May 19, 2026 | |||||||||
|
Nash Marc
· Officer
Sell
−$6K
|
Nash Marc | Officer | Sell | $3.70 | −2K | −$6K | 38K | – | May 15, 2026 | May 19, 2026 | |||||||||
|
Brottem John L.
· Officer
Sell
−$10K
|
Brottem John L. | Officer | Sell | $3.70 | −3K | −$10K | 30K | – | May 15, 2026 | May 19, 2026 | |||||||||
|
Leonard Braden Michael
· 10% Owner
Exercise or conversion (M/X/C)
$1.6M
|
Leonard Braden Michael | 10% Owner | Exercise or conversion (M/X/C) | $5.00 | 323K | $1.6M | 2.5M | – | May 15, 2026 | May 18, 2026 | |||||||||
|
Leonard Braden Michael
· 10% Owner
Exercise or conversion (M/X/C)
$484K
|
Leonard Braden Michael | 10% Owner | Exercise or conversion (M/X/C) | $5.00 | 97K | $484K | 2.2M | – | May 11, 2026 | May 12, 2026 | |||||||||
103 reporting institutions disclosed OM position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.